Study group, n (%) |
Control | 19 423 (47.3) | 11 227 (57.8) | 8196 (42.2) | 1c | |
Intervention | 21 619 (52.7) | 12 080 (55.9) | 9539 (44.1) | 1.08 (0.97 to 1.20) | 0.146 |
|
Sex, n (%) |
Male | 19 039 (46.4) | 11 287 (59.3) | 7752 (40.7) | 1c | |
Female | 22 003 (53.6) | 12 020 (54.6) | 9983 (45.4) | 1.21 (1.16 to 1.26) | <0.001 |
|
Age groups, years, n (%) |
50–54 | 11 991 (29.2) | 7231 (60.3) | 4760 (39.7) | 1c | |
55–59 | 10 765 (26.2) | 6155 (57.2) | 4610 (428) | 1.13 (1.07 to 1.20) | <0.001 |
60–64 | 9910 (24.2) | 5278 (53.3) | 4632 (46.7) | 1.32 (1.23 to 1.41) | <0.001 |
65–69 | 8376 (20.4) | 4643 (55.4) | 3733 (44.6) | 1.21 (1.12 to 1.30) | <0.001 |
|
Smoking, n (%) |
Never smokers | 14 028 (48.3) | 7184 (51.2) | 6844 (48.8) | 1c | |
Smokers | 6908 (23.8) | 4268 (61.8) | 2640 (38.2) | 0.65 (0.61 to 0.70) | <0.001 |
Ever smokers | 8105 (27.9) | 3946 (48.7) | 4159 (51.3) | 1.10 (1.01 to 1.20) | 0.020 |
|
Alcohol consumption, n (%) |
Non drinkers | 16 352 (61.8) | 8675 (53.1) | 7677 (46.9) | 1c | |
Low-risk drinkers | 9349 (35.3) | 4723 (505) | 4626 (49.5) | 1.10 (1.04 to 1.17) | 0.001 |
High-risk drinkers | 760 (2.9) | 463 (60.9) | 297 (39.1) | 0.73 (0.62 to 0.86) | <0.001 |
|
Body mass index, n (%) |
Low weight | 539 (2.4) | 335 (62.1) | 204 (37.9) | 1c | |
Normal weight | 5351 (24.2) | 2784 (52.0) | 2567 (48.0) | 1.51 (1.24 to 1.84) | <0.001 |
Overweight | 9193 (41.5) | 4641 (50.5) | 4552 (49.5) | 1.61 (1.34 to 1.94) | <0.001 |
Obesity | 6474 (29.2) | 3382 (50.2) | 3092 (47.8) | 1.50 (1.24 to 1.82) | <0.001 |
Morbid obesity | 583 (2.6) | 346 (59.3) | 237 (40.7) | 1.12 (0.88 to 1.43) | 0.356 |
|
Socioeconomic deprivation index quintiles, n (%) |
Q1 | 7648 (20.1) | 4659 (60.9) | 2989 (39.1) | 1c | |
Q2 | 7724 (20.2) | 4272 (55.3) | 3452 (44.7) | 1.27 (1.16 to 1.39) | <0.001 |
Q3 | 7511 (19.7) | 3786 (50.4) | 3725 (49.6) | 1.53 (1.41 to 1.68) | <0.001 |
Q4 | 7706 (20.2) | 4169 (54.1) | 3537 (45.9) | 1.33 (1.21 to 1.46) | <0.001 |
Q5 | 7547 (19.8) | 4761 (63.1) | 2786 (36.9) | 0.92 (0.82 to 1.03) | 0.168 |
|
Visits to PCC during the study period, n (%) |
0 | 10 163 (24.8) | 7222 (71.1) | 2941 (28.9) | 1c | |
1 | 3295 (8.0) | 2023 (61.4) | 1272 (38.6) | 1.53 (1.39 to 1.69) | <0.001 |
2 | 3246 (7.9) | 1881 (57.9) | 1365 (42.1) | 1.75 (1.59 to 1.92) | <0.001 |
3 | 3081 (7.5) | 1647 (53.5) | 1434 (46.5) | 2.10 (1.92 to 2.30) | <0.001 |
4 | 2841 (6.9) | 1462 (51.5) | 1379 (48.5) | 2.28 (2.04 to 2.54) | <0.001 |
≥ 5 | 18 416 (44.9) | 9072 (49.3) | 9344 (50.7) | 2.48 (2.31 to 2.66) | <0.001 |
|
Clinical risk group, n (%) |
Without dominant chronic illness | 15 827 (40.6) | 9090 (57.4) | 6737 (42.6) | 1c | |
With dominant chronic illness | 23 132 (59.4) | 12 465 (53.9) | 10 667 (46.1) | 1.15 (1.10 to 1.21) | <0.001 |